Toni WEINSCHENK,Andrea MAHR,Jens FRITSCHE,Phillip MUELLER,Anita WIEBE,Sarah KUTSCHER
申请号：
US15917098
公开号：
US20180207252A1
申请日:
2018.03.09
申请国别(地区):
US
年份:
2018
代理人:
摘要：
A method of treating a patient who has a cancer includes administering to said patient a composition containing a population of activated T cells that selectively recognize the cancer cells in the patient that aberrantly express a peptide consisting of the amino acid sequence of GVYDGEEHSV (SEQ ID NO: 303), in which the peptide is in a complex with an MHC molecule.
